J0573
HCPCSBupren/nal 3.1 to 6mg bupren
Official HCPCS Level II long descriptor
Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
HCPCS Level II code J0573 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Bupren/nal 3.1 to 6mg bupren
Added to HCPCS: 2015-01-01
Nearby codes in J0
- J0528Inj fosfomycin disodium 20mg
- J0558Peng benzathine/procaine inj
- J0561Penicillin g benzathine inj
- J0565Inj, bezlotoxumab, 10 mg
- J0567Inj., cerliponase alfa 1 mg
- J0570Buprenorphine implant 74.2mg
- J0571Buprenorphine oral 1mg
- J0572Bupren/nal up to 3mg bupreno
- J0574Bupren/nal 6.1 to 10mg bupre
- J0575Bupren/nal over 10mg bupreno
- J0577Inj, brixadi, 7 days or less
- J0578Inj brixadi, more than 7 day
- J0582Bivalirudin (endo) 1 mg
- J0583Bivalirudin
- J0584Injection, burosumab-twza 1m
- J0585Injection,onabotulinumtoxina
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.